Viewing Study NCT02114502


Ignite Creation Date: 2025-12-25 @ 4:02 AM
Ignite Modification Date: 2026-02-28 @ 10:35 PM
Study NCT ID: NCT02114502
Status: WITHDRAWN
Last Update Posted: 2014-07-11
First Post: 2014-04-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module